# Avicenna Biosciences

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/avicenna-biosciences

- Industry: Biotechnology
- Headquarters: Durham, US
- Total disclosed funding: $3M
- Latest round: Seed (Apr 15, 2022)
- Investors on record: 1

## About

Based in North Carolina, US, and founded in 2020 by Pieter Burger, Thomas Kaiser, Avicenna Biosciences, Inc., operates as a biotechnology company that offers various research and development solutions. In November 2023, Avicenna Biosciences raised USD 6 million in venture debt funding from unspecified investors.

The company offers research and development solutions for pharmaceutical companies, enabling them to address and rectify deficiencies in their drug development processes.

The company uses machine learning algorithms to analyze vast amounts of data to identify key insights and optimize drug formulations for improved performance.

## Funding rounds

- Seed, Apr 15, 2022, $3M — DCVC

## Investors

- DCVC (https://capitalatlas.ai/funds/dcvc) — Seed